Bibliographie

• 1) Bloom and Fawcett: a textbook of histology. 12^ème édition, (1994); chap 10, p 294-308
• 2) Thorburn J., McMahon M., Thorburn A. (1994) Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocytes hypertrophy. J. Biol. Chem., 269, 30580-30586.
• 3) Chien K.R., Knowlton K.U., Zhu H., Chien S. (1991) Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptative physiologic response. The FASEB Journal, 5, 3037-3046.
• 4) Pinson A., Tirosh R., Tremblover V., and Shoshami E., (1996) Oxygen deprivation and reoxygenation augment prostacyclin synthesis in cultured ventricular myocytes. Prostaglandins Leukot. Essent. Fatty Acids 54: 211-215.
• 5) Oudot F., Grynberg A., and Sergiel J.P. (1995) Eicosanoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation. And polyunsaturated fatty acids. Am J. Physiol 268: H308-315
• 6) Church D.J., Braconi S., Van der Bent V., Vallotton M. B., and U. Lang. (1994) Protein kinase C-dependent prostaglandin production mediates angiotensin II-induced atrial-natriuretic peptide release. Biochem. J. 298: 451-456
• 7) Van der Bent V., Church D.J., Vallotton M.B., Meda P., Kem D.C., Capponi A.M., and U. Lang (1994) [Ca⁺⁺]I and protein kinas C in vasopressin-induced prostacyclin and ANP release in rat cardiomyocytes. Am. J. Physiol. 266: H57-H605
• 8) Dennis E.a. (1994) Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269: 13057-13060.
• 9) Kramer R.M. and Sharp J.D. (1997) Structure, function and regulation ok Ca⁺⁺ -sensitive cytosolic phosphlipase A₂ (cPLA₂ ). FEBS Lett. 410: 49-53.
• 10) Smith W.L. (1991) The aspirin and heme binding sites of PGG/H synthase. Adv. Prostaglandin. Thromboxane. Leukot. Res. 21A: 77-80
• 11) Picot D. (1994) Prostaglandin h synthase: implications for membrane structure: FEBS Lett., 346: 21-25
• 12) Luong C. (1996) Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2: Nat. Struct. Biol., 3: 927-933
• 13) Morita I. (1995) Different and intracellular locations for prostaglandinsendoperoxyde H synthase-1 and -2. J. Biol. Chem. 270: 10902-10908
• 14) Spencer A.G. (1998) Subcellular localisation of prostaglandin endoperoxyde H synthase-1 and -2 by immunoelectron microscopy: J. Biol. Chem 273: 9886-9893
• 15) Hia T., (1992), Human cyclooxygenase-2 cDNA: Proc Natl Acad Sci. U.S.A. 89: 7384-7388
• 16) Mitchell J.A. (1995) cycloxygenase-2: regulation and relevance in inflammation: biochem Pharmacol. 50: 1535-1542
• 17) Masferrer JL, (1994) Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonulcerogenic. Proc. Natl. Acad Sci U.S.A. 91: 3228-3232
• 18) Seibert K. (1994) Role of inducible cyclooxygenase (COX-2) in inflammation 4: 17-23
• 19) Smith W.L., Dewitt, D.L.(1996) Prostaglandin Endoperoxide H Synthase-1 and -2. Advances in immunology, vol 62: 167-215. Review
• 20) Adderley SR, Fitzgerald DJ., (1999) Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases ½-mediated induction of cyclooxygenase-2. J.Biol. Chem 274(8):5038-46
• 21) Dowd NP, Scully M, Adderley SR, Cunningham AJ, Fitzgerald DJ. (2001) Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. J. Clin. Invest. 108(4): 585-590
• 22) Wong SCY, Fukuchi M., Melnyk P, Rodger I. (1998) Induction of cyclooxygenase-2 and activation of nuclear factor-kB in myocardium of patients with congestive heart failure. Circulation 98: 100-103
• 23) Shinmura K., Tang XL., Wang Y., Xuan YT., Liu SQ., Takano H., Bhatnagar A., Bolli R. (2000) Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of preconditioning in conscious rabbits. Proc. Natl. Acad. SCI., USA, 97(18): 10197-10202
• 24) Yang X. Ma N. Szaboles MJ, Zhong J, Athan E Sciacca RR Michler R Anderson GD Wiese JF, Leahy K, Gregory S, Cannon PJ. (2000) Upregulation of COX-2 during allograft rejection. Circulation 1001(4): 430
• 25) Wong SCY. Fukuchi M. Melnik P. Rodger I. Giaid A. (1998). Induction of cyclooxygenase-2 and activation of nuclear factor kB in myocardium of patients with congestive heart failure. Circulation 98: 100-103
• 26) Guyton and Hall: Textbook of medical physiology, 9ème edition, (1996), unites IV. V, XIV.
• 27) Teerlink J.R. (1994) The evolving role of angiotensin-converting enzyme inhibition in heart failure: expanding the protective envelope. J. Cardiovasc. Pharmacol. 24:S32-7
• 28) Fouad-Tarazi F.M. (1994) Hemodynamic effects of inhibitors of the rennin-angiotensin system. J. Hypertens.12: S25-9
• 29) Baker K.M. , Booz G. W., and Dostal D.E. (1992) Cardiac actions of angiotesin II: role of an intracardiac renin-angiotensin system. Annu. Rev. Physiol. 54 : 227-241
• 30) Sechi L.A., Griffin C.A., Grady E.F., Kalinyak J.E., and Schambelan M., (1992) Characterization of angiotensin II receptor subtypes in rat heart. Circ. Res. 71: 1482-1489.
• 31) Timmerans P.B. Wong P.C., Chiu A.T. and Heberlin W.F. (1991) Nonpeptide angiotensin II receptors antagonists. Trends Pharmacol. Sci. 12: 55-62
• 32) Meggs L.G., Coupet J., Huang H., Li W.C.P., Capasso J.M., Homcy C.J., and Anversa P., (1993) Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ. Res. 72: 1149-1162
• 33) Suzuki J., Matsubara H., Urakami M., and Inada M., (1993) Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ. Res. 73: 439-447
• 34) Timmerans P.B., Wong P., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye J.M., and Smith RD. (1993) Angiotensin II receptors and angiotensin II receptors antagonists. Pharmacol. Rev. 45: 205-251.
• 35) Pönicke K., Heinroth-Hoffmann I., Brodde OE. Becker K. (1997) Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells.
• British journal of pharmacology 121: 118-124
• 36) Inoue A., Yanagisawa M., Kimura S., Kasuya Y., and Myauchi T. (1989) The human endothelin family - 3 structurally and pharmaologycally distinct isopeptides predicted by 3 separate genes. Proc. Natl acad. Sci. USA 86: 2863-2867
• 37) Krämer B.K. Ackermann M., Kohler S.M., and Riegger G.A.J. (1994) Role of endothelin in hypertension. Clin. Investig. 72: 88-93
• 38) Guyton and Hall, textbook of medical physiology, 9^ème édition, 1996, p.
• 39) Hirata Y., Takagi Y., Fukuda Y., and Marumo F. (1989) endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 78: 225-228
• 40) Takuwa N., Takuwa Y., Yanagisawa K., Yamashita K., and Masaki T. (1989 A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem. 264: 7856-7861
• 41) Krämer B.K., Nishida M., Kelly R.A., and Smith T.W. (1992) Endothelins. Myocardial action of a new class of cytokines. Circulation 85: 350-356.
• 42) Ito H., Hirata Y., Hiroe M., Tsujino M., Adachi S., Takamoto T., Nitta M., Taniguchi K., and Marumo F., (1991) Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ. Res. 69: 209-215
• 43) Shubeita H.E., McDonough P.M., Harris A.N., Knowlton K.U., Glembotski C.C., Brown J.H., and Chien K.R. (1990) Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J. Biol. Chem. 265: 20555-20562
• 44) Suzuki T., Hoshi H., and Mitsui Y. (1990) Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium. FEBS Lett. 268: 149-151
• 45) Hahn A.W., Resink T.J., Scott B.T., Powell J., Dohi Y., and Buhler F.R. (1990) Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1: 649-659
• 46) Ohta K., Hirata Y., Imai T., Kanno K., Emori T., Shichiri M., and Marumo F. (1990) Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem. Biophys. Res. Commun. 169: 578-584
• 47) Sakamoto H., sasaki S., Hirata Y., Imai T., Ando K., Ida T., Sakurai M., Yanagisawa T., Masaki T., and Marumo F., (1990) Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys. Res., Commun. 169: 462-468
• 48) Shichiri M., Hirata Y., Nakajima T., Ando K., Imai., Yanagisawa M., Masaki T., and Marumo F. (1991) endothelin-1 is an autocrine-paracrine growth factor for human cancer cell lines. J. Clin. Invest. 87: 1867-1871
• 49) Ito h., Adachi S., Tamamori M., Fujisaki H., Tanaka M., Lin M., Akimoto H., Marumo F., and Hiroe M. (1996) Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism. J. Mol. Cell. Cardiol.28: 1271-1277
• 50) Iwanaga Y., Kihara Y., Hasegawa K., Inagaki K., Yoneda T., Kaburagi S., Araki M., and Sasayama S., (1998) Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from the compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 98: 2065-2073.
• 51) Kobayashi T., Miyauchi T., Sakai S., Kobayashi M., Yamaguchi I., Goto K., and Sugishita Y., (1999) Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failling rat heart. Am. J. Physiol. 276: H1197-11206
• 52) Guyton and Hall: Textbook of medical physiology, 9ème edition, (1996), unité XIV.
• 52b) Ikeda U, Hyman R, Smith TW, Medford RM, Aldosterone-mediated regulation of Na+, K+-ATPase gene expression in adult and neonatal rat cardiomyocytes. J Biol Chem. 1991, 266: 12058-12066
• 53) Korichneva I., Puceat M., Millanvoye-Van Brussel E., Geraud G., Vassort G.(1995) Aldosterone modulates both the Na+/H+ antiport and Cl-/HCO3- exchanger in cultured neonatal rat cardiac cells. J. Mol. Cell. Cardiol. 27: 2521-2528
• 54) Benitah J.P. Vassort G. (1999) Aldosterone upregulates Ca⁺⁺ current in adult rat cardiomyocytes. Circ. Res. 1999; 85: 1139-1145
• 55) Lombes M., Alfaidy N., Eugene E., Lessana A., Farman N., Bonvalet J.P. (1995). Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 b-hydroxysteroid dehydrogenase in the human heart. Circulation. 92: 175-182
• 56) Brilla C.G., Matsubara L.S., Weber K.T (1993) Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary an secondary hyperaldosteronism. J. Mol. Cell Cardiol. 25: 563-574
• 57) Robert V., Thiem N.V., Cheav S.L., Mouas C., Swynghdauw B., Decayre C., (1994) Increased cardiac types I and II collagen mRNAs in aldosterone-salt hypertension. Hypertension 24: 30-36
• 58) Young M., Fullerton M., Dilley R., Funder J.W., (1994) Mineralocorticoids, hypertension and cardiac fibrosis. J. Clin. Invest. 93: 2578-2583
• 59) Robert V., Heymes C., Silvestre J.S., Sabri A., Swynghdauw B., Decayre C. (1999) Angiotensin AT1 receptor subtype as a cardiac target of aldosterone. Hypertension 33:981-986
• 60) Williams Textbook of endocrinology, 9ème edition, chapitre 15, p. 761-768
• 61) Grohe C. Kahlert S. Lobbert K. Stimpel M. Karas RH. Vetter H. Neyses L. (1997) Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416(1): 107-112
• 62) Chang WC, Nakao J, Orimo H, Murota SI. (1980) Stimulation of prostaglandin cyclooxygenase and prostacyclin synthase activities by estradiol in rat aortic smooth muscle cells. Biochim Biophys Acta 620(3): 472-482
• 63) Ghanam K, Lavagna C, Burgaud JL, Javellaud J, Ea-Kim L, Oudart N. (2000) Involvement of cyclooxygenase-2 in the protective effect of 17b-estradiol on hypercholesterolemic rabbit aorta. Biochem. Biophys. Res. Commun. 275(2): 696-703
• 64) Shoda T. Hatanaka K. Saito M. Majima M. Ogino M. Harada Y. Nishijima M. Katori M. Yamamoto S. (1995). Induction of cyclooxygenase type 2 (COX-2) in rat endometrium at the peak of serum estradiol during the estrus cycle. Jpn. J. Pharmacol. 69(3) : 289-291
• 65) Rebsamen MC, Church DJ, Morabito D, Vallotton MB, Lang U. (1997), Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes. Am j Physiol. 273 : E922-931
• 66) Church DJ, Braconi-Quintaje S, van der Bent V, Vallotton MB, Lang U. (1994) Protein kinase c-dependent prostaglandin production mediates angiotensin II-induced atrial natriuretic peptide release. Biochem J. 298 :451-456
• 67) Ohnaka K, Numaguchi K, Yamakawa T, Inagami T. (2000) Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 35: 68-75
• 68) Young W. Mahboubi K. Haider A. Li I Ferreri NR. (2000) Cyclooxygenase-2 is required for tumor necrosis factor-alpha- and angiotensin II-mediated proliferation of vascular smooth muscle cells. Circ. Res. 86(8): 906-914
• 69) Schlondorff D, DeCandido S. Satriano JA. (1987) Angiotensin II stimulates phospholipases C and A2 in cultured rat mesangial cells. Am. J. Physiol. 253:C113-C120
• 70) Gimbrone MAJr. Alexander RW. (1975) Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science 189: 219-220
• 71) Scheuren N. Jacobs N. Ertl G. Schorb W. (2002) Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction. Journal of molecular and cellular cardiology. 34:29-37
• 72) Cheng HF, Wang JL, Zhang MZ, Miyazaki, Ichikawa I, McKanna, Harris RC, (1999), Angiotensin II attenuates renal cortical cyclooxygenase-2 expression J.Clin. Invest. 103: 953-961
• 73) Hughes AK. Padilla E. Kutchera WA. Michael JR. Kohan DE. (1995) Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells. Kidney int. 47(1): 53-61
• 74) Coroneos E. Kester M. Thomas P. Dunn MJ. (1995) Endothelin regulates PGE2 formation in rat mesangial cells through induction of prostaglandin endoperoxide synthase-2. Adv. Prostaglandin Thromboxane Leukot. Res. 23: 117-119
• 75) Kester M. Coroneos E. Thomas PJ. Dunn MJ. (1994) Endothelin stimulates prostaglandin endoperoxyde synthase-2 mRNA expression and protein synthesis through a tyrosine kinase-signaling pathway in rat mesangial cells. J. Biol. Chem. 269(36): 22574-80
• 76) Koyama Y. Mizobata T. Yamamoto N. Hashimoto H. Matsuda T. Baba A. (1999) Endothelins stimulate expression of cyclooxygenase-2 in rat cultured astrocytes. Neurochem. 73(3): 1004-1011
• 77) Sorli CH, Zhang HJ, Armstrong MB, Rajotte RV, Maclouf J, Robertson RP, (1998), Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and co-ordinately regulated by interleukin-1 in the pancreatic islet. Proc. Natl. Acad. Sci. USA; 95: 1788-1793
• 78) Casal AJ. Silvestre JS. Delcayre C. Capponi AM. (2002) submitted
• 79) Engstrom T. (2001) The regulation by ovarian steroids of prostaglandin synthesis and prostaglandin-induced contractility in non-pregnant rat myometrium. Modulating effects of isoproterenol. Journal of endocrinology. 169: 33-41
• 80) Sato T. Michizu H. Hashizume K. Ito A. (2001) Hormonal regulation of PGE2 and COX-2 production in rabbit uterine cervical fibroblasts. J. Appl. Physiol 90(4): 1227-1231